Grants and Contributions:
Title:
Biocomposite Spinal Implants for Orthopedic Surgery
Agreement Number:
984931
Agreement Value:
$999,000.00
Agreement Date:
Sep 1, 2021 - Mar 29, 2024
Description:
Octane EXO is focused on the development, manufacturing and regulatory approval of innovative spinal implants formed from a proprietary biocomposite that provides superior bone tissue integration for spinal reconstruction. This project is directed to the completion of product and process R&D along with the the qualification of the manufacturing methods, as key objectives leading to submission for regulatory approval by international health agencies. Following regulatory approval, Octane EXO will commercialize via leading multinational partners.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Kingston, Ontario, CA K7K 6Z1
Reference Number:
172-2021-2022-Q4-984931
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
730206679
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 249,000 dollars.
Amendment Date
Sep 20, 2023
Recipient's Legal Name:
Octane Exo Inc.
Federal Riding Name:
Kingston and the Islands
Federal Riding Number:
35044
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3391
Amendments: